# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-042683
Filing Date
2021-08-16
Accepted
2021-08-16 08:41:15
Documents
69
Period of Report
2021-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0621_180lifesciences.htm iXBRL | 10-Q | 966339
2 | FORM OF STOCK OPTION AGREEMENT (INDEPENDENT DIRECTORS AUGUST 2021 GRANTS) | f10q0621ex10-9_180lifesci.htm | EX-10.9 | 87471
3 | CERTIFICATION | f10q0621ex31-1_180lifesci.htm | EX-31.1 | 10830
4 | CERTIFICATION | f10q0621ex31-2_180lifesci.htm | EX-31.2 | 10518
5 | CERTIFICATION | f10q0621ex32-1_180lifesci.htm | EX-32.1 | 3887
6 | CERTIFICATION | f10q0621ex32-2_180lifesci.htm | EX-32.2 | 3793
12 | GRAPHIC | image_001.jpg | GRAPHIC | 2410
| Complete submission text file | 0001213900-21-042683.txt |  | 5779427

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL PRESENTATION FILE | atnf-20210630_pre.xml | EX-101.PRE | 323390
8 | XBRL LABEL FILE | atnf-20210630_lab.xml | EX-101.LAB | 633972
9 | XBRL DEFINITION FILE | atnf-20210630_def.xml | EX-101.DEF | 306581
10 | XBRL CALCULATION FILE | atnf-20210630_cal.xml | EX-101.CAL | 34882
11 | XBRL SCHEMA FILE | atnf-20210630.xsd | EX-101.SCH | 85668
13 | EXTRACTED XBRL INSTANCE DOCUMENT | f10q0621_180lifesciences_htm.xml | XML | 601155

Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38105 | Film No.: 211174774
SIC: 2834 Pharmaceutical Preparations